| abstract |
Glucagon-like insulinotropic peptide (GLP-1(7-37))nanalogs and derivatives are disclosed. The analogs includenamino acid substitutions, amino and carboxyl terminalnmodifications, and C 6 -C 10 acylations. The claimed compoundsnstimulate the secretion or biosynthesis of insulin in poorlynfunctioning beta cells and are therefore useful in treatingnType II diabetics |